FoxO1 knockdown inhibits RANKL ‐induced osteoclastogenesis by blocking NLRP3 inflammasome activation
Oral Diseases · 2024
DOI: 10.1111/odi.14800 ↗At a glance
Journal article in Oral Diseases, 2024. Written by Zhanqi Wang and 8 co-authors. Institution: State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, C…. Major MEDLINE topics: Forkhead Box Protein O1, NLR Family, Pyrin Domain-Containing 3 Protein, RANK Ligand, Osteoclasts. Cited 6 times so far (Crossref); 54 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.
Abstract (original language)
Objectives
This study aimed to elucidate the connection between osteoclastic forkhead transcription factor O1 ( FoxO1 ) and periodontitis and explore the underlying mechanism by which FoxO1 knockdown regulates osteoclast formation. Materials and Methods A conventional ligature‐induced periodontitis model was constructed to reveal the alterations in the proportion of osteoclastic FoxO1 in periodontitis via immunofluorescence staining. Additionally, RNA sequencing (RNA‐seq) was performed to explore the underlying mechanisms of FoxO1 knockdown‐mediated osteoclastogenesis, followed by western blotting, quantitative polymerase chain reaction, and enzyme‐linked immunosorbent assay.
Results
FoxO1 + osteoclasts were enriched in the alveolar bone in experimental periodontitis. Moreover, FoxO1 knockdown led to impaired osteoclastogenesis with low expression of osteoclast differentiation‐related genes, accompanied by an insufficient osteoclast maturation phenotype. Mechanistically, RNA‐seq revealed that the nuclear factor kappa B (NF‐κB) and nucleotide‐binding oligomerization domain‐like receptor family pyrin domain containing 3 (NLRP3) inflammasome signaling pathways were inhibited in FoxO1 ‐knockdown osteoclasts. Consistent with this, MCC950, an effective inhibitor of the NLRP3 inflammasome, substantially attenuated osteoclast formation.
Conclusions
FoxO1 knockdown contributed to the inhibition of osteoclastogenesis by effectively suppressing NF‐κB signaling and NLRP3 inflammasome activation. This prospective study reveals the role of FoxO1 in mediating osteoclastogenesis and provides a viable therapeutic target for periodontitis treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
- Department of Oral Implantology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
ORCID profiles: Zhanqi Wang, Yi Xiong, Yingying Wu
Funding
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
Cite
APA
Wang, Z., Luo, W., Zhang, G., Li, H., Zhou, F., Wang, D., Feng, X., Xiong, Y., & Wu, Y. (2024). FoxO1 knockdown inhibits RANKL ‐induced osteoclastogenesis by blocking NLRP3 inflammasome activation. Oral Diseases. https://doi.org/10.1111/odi.14800
Vancouver
Wang Z, Luo W, Zhang G, Li H, Zhou F, Wang D, et al. FoxO1 knockdown inhibits RANKL ‐induced osteoclastogenesis by blocking NLRP3 inflammasome activation. Oral Diseases. 2024. doi:10.1111/odi.14800
BibTeX
@article{Wang2024,
author = {Wang, Zhanqi and Luo, Wenxin and Zhang, Guorui and Li, Haiyun and Zhou, Feng and Wang, Dongyang and Feng, Xuan and Xiong, Yi and Wu, Yingying},
title = {FoxO1 knockdown inhibits RANKL ‐induced osteoclastogenesis by blocking NLRP3 inflammasome activation},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14800}
}
EUVIMED